RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,987,147 | -33.0% | 593,002 | 0.0% | 0.06% | -30.9% |
| Q2 2023 | $7,448,105 | -71.4% | 593,002 | -62.5% | 0.09% | -74.3% |
| Q1 2023 | $26,059,674 | +7.8% | 1,582,251 | -2.2% | 0.37% | +1.7% |
| Q4 2022 | $24,178,194 | -63.6% | 1,618,353 | -45.5% | 0.36% | -64.2% |
| Q3 2022 | $66,382,000 | +28.1% | 2,967,445 | -4.1% | 1.00% | +19.8% |
| Q2 2022 | $51,803,000 | -57.3% | 3,092,726 | -23.6% | 0.84% | -43.7% |
| Q1 2022 | $121,237,000 | -2.1% | 4,050,688 | +0.4% | 1.49% | +17.8% |
| Q4 2021 | $123,895,000 | +28.8% | 4,034,356 | +32.2% | 1.26% | +10.8% |
| Q3 2021 | $96,189,000 | -7.9% | 3,050,702 | +6.9% | 1.14% | -17.6% |
| Q2 2021 | $104,429,000 | +18.8% | 2,854,040 | +12.2% | 1.38% | +6.7% |
| Q1 2021 | $87,898,000 | +92.9% | 2,542,619 | +131.9% | 1.30% | +76.2% |
| Q4 2020 | $45,561,000 | -0.3% | 1,096,280 | +2.2% | 0.74% | -21.5% |
| Q3 2020 | $45,699,000 | – | 1,073,009 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |